FDA Issues Final cGMP Guidance
By Daniel R. Matlis Yesterday, on the heels of the release of a critical Institute of Medicine Report, the FDA issued a Final Guidance …
By Daniel R. Matlis Yesterday, on the heels of the release of a critical Institute of Medicine Report, the FDA issued a Final Guidance …
By Daniel R. Matlis According to a report issued by the Institute of Medicine (IOM), the FDA suffers from a lack of clear regulatory authority, …
FDA Drug Safety System Needs Fixing, IOM Report Says Read More »
By Leslie Gladstone Restaino, Esq. ImClone Systems, Inc. is reeling from a court decision Monday invalidating ownership of a significant patent for the company’s cancer …
ImClone Loses Patent Decision for Cancer Drug Erbitux Read More »
By Daniel R. Matlis Recently, I wrote an article calling for consistent federal regulatory requirements for the practice of compounding. Last month, the US District …
The U.S. Food and Drug Administration (FDA) yesterday approved the AbioCor®, the world’s first completely self-contained, implantable Replacement Heart. This approval provides patients suffering from …
FDA Approves First Implantable Replacement Heart Read More »
By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the …
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the …
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
On August 3, 2006 MRO Software announced that it has agreed to be acquired by IBM. So, what the impact on Life-Sciences Customers? I think …
The impact of IBM’s Acquisition of MRO Software on the Life-Sciences Market Read More »
I recently read an article on the Free Software Foundation’s Website entitled “Regulatory compliance is no reason to lock up users” The author states that …
This week, Scott Gottlieb, MD Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration made an interesting speech before the 2006 …
Doctors Don’t Treat Populations, They Treat Individual Patients Read More »
During my senior year, I was lucky to have a few job offers to evaluate. The top two were from Johnson & Johnson and Exxon. …
"Medicine is for the People, not for the Profits." Read More »
By Daniel R. Matlis It’s 3:00 AM and your newborn baby wakes up crying. You want to go back to sleep, but his circadian rhythm …